Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
274
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Biohaven Ltd market cap is $1.87B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Biohaven Ltd 52 week high is $18.24 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Biohaven Ltd 52 week low is $8.03 as of November 21, 2026.
Biohaven Ltd stock price today is $12.39.
Biohaven Ltd stock price yesterday was $13.65.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Biohaven Ltd's P/E ratio is -3.21.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Biohaven Ltd P/B ratio is -19.0498.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Biohaven Ltd 50-day moving average is $13.42.